• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用可行性研究中的智能手机数据对情绪障碍患者进行分类和聚类。

Classifying and clustering mood disorder patients using smartphone data from a feasibility study.

作者信息

Langholm Carsten, Breitinger Scott, Gray Lucy, Goes Fernando, Walker Alex, Xiong Ashley, Stopel Cindy, Zandi Peter, Frye Mark A, Torous John

机构信息

Division of Digital Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, 02115, USA.

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, 55902, USA.

出版信息

NPJ Digit Med. 2023 Dec 21;6(1):238. doi: 10.1038/s41746-023-00977-7.

DOI:10.1038/s41746-023-00977-7
PMID:38129571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10739731/
Abstract

Differentiating between bipolar disorder and major depressive disorder can be challenging for clinicians. The diagnostic process might benefit from new ways of monitoring the phenotypes of these disorders. Smartphone data might offer insight in this regard. Today, smartphones collect dense, multimodal data from which behavioral metrics can be derived. Distinct patterns in these metrics have the potential to differentiate the two conditions. To examine the feasibility of smartphone-based phenotyping, two study sites (Mayo Clinic, Johns Hopkins University) recruited patients with bipolar I disorder (BPI), bipolar II disorder (BPII), major depressive disorder (MDD), and undiagnosed controls for a 12-week observational study. On their smartphones, study participants used a digital phenotyping app (mindLAMP) for data collection. While in use, mindLAMP gathered real-time geolocation, accelerometer, and screen-state (on/off) data. mindLAMP was also used for EMA delivery. MindLAMP data was then used as input variables in binary classification, three-group k-nearest neighbors (KNN) classification, and k-means clustering. The best-performing binary classification model was able to classify patients as control or non-control with an AUC of 0.91 (random forest). The model that performed best at classifying patients as having MDD or bipolar I/II had an AUC of 0.62 (logistic regression). The k-means clustering model had a silhouette score of 0.46 and an ARI of 0.27. Results support the potential for digital phenotyping methods to cluster depression, bipolar disorder, and healthy controls. However, due to inconsistencies in accuracy, more data streams are required before these methods can be applied to clinical practice.

摘要

对临床医生来说,区分双相情感障碍和重度抑郁症可能具有挑战性。诊断过程可能会受益于监测这些疾病表型的新方法。智能手机数据在这方面可能会提供一些见解。如今,智能手机收集密集的多模态数据,从中可以得出行为指标。这些指标中的不同模式有可能区分这两种疾病。为了检验基于智能手机的表型分析的可行性,两个研究地点(梅奥诊所、约翰·霍普金斯大学)招募了患有双相I型障碍(BPI)、双相II型障碍(BPII)、重度抑郁症(MDD)的患者以及未确诊的对照者,进行了一项为期12周的观察性研究。研究参与者在他们的智能手机上使用一款数字表型分析应用程序(mindLAMP)来收集数据。在使用过程中,mindLAMP收集实时地理位置、加速度计和屏幕状态(开/关)数据。mindLAMP还用于进行电子移动评估(EMA)。然后,mindLAMP数据被用作二元分类、三组k近邻(KNN)分类和k均值聚类中的输入变量。表现最佳的二元分类模型能够以0.91的曲线下面积(AUC)(随机森林)将患者分类为对照或非对照。在将患者分类为患有MDD或双相I/II型方面表现最佳的模型的AUC为0.62(逻辑回归)。k均值聚类模型的轮廓系数为0.46,调整兰德指数为0.27。结果支持数字表型分析方法对抑郁症、双相情感障碍和健康对照进行聚类的潜力。然而,由于准确性存在不一致性,在这些方法能够应用于临床实践之前,还需要更多的数据流。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab1d/10739731/8cc73fb7787a/41746_2023_977_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab1d/10739731/8cc73fb7787a/41746_2023_977_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab1d/10739731/8cc73fb7787a/41746_2023_977_Fig1_HTML.jpg

相似文献

1
Classifying and clustering mood disorder patients using smartphone data from a feasibility study.利用可行性研究中的智能手机数据对情绪障碍患者进行分类和聚类。
NPJ Digit Med. 2023 Dec 21;6(1):238. doi: 10.1038/s41746-023-00977-7.
2
Digital Phenotyping for Mood Disorders: Methodology-Oriented Pilot Feasibility Study.用于心境障碍的数字化表型分析:面向方法学的初步可行性研究。
J Med Internet Res. 2023 Dec 29;25:e47006. doi: 10.2196/47006.
3
Digital phenotyping data and anomaly detection methods to assess changes in mood and anxiety symptoms across a transdiagnostic clinical sample.用于评估跨诊断临床样本中情绪和焦虑症状变化的数字表型数据及异常检测方法。
Acta Psychiatr Scand. 2025 Mar;151(3):388-400. doi: 10.1111/acps.13712. Epub 2024 May 28.
4
Behavioral and Self-reported Data Collected From Smartphones for the Assessment of Depressive and Manic Symptoms in Patients With Bipolar Disorder: Prospective Observational Study.使用智能手机收集的行为和自我报告数据可用于评估双相情感障碍患者的抑郁和躁狂症状:前瞻性观察研究。
J Med Internet Res. 2022 Jan 19;24(1):e28647. doi: 10.2196/28647.
5
Relapse prediction in schizophrenia with smartphone digital phenotyping during COVID-19: a prospective, three-site, two-country, longitudinal study.COVID-19 期间使用智能手机数字表型分析预测精神分裂症复发:一项前瞻性、三中心、两国纵向研究
Schizophrenia (Heidelb). 2023 Jan 27;9(1):6. doi: 10.1038/s41537-023-00332-5.
6
Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.给编辑的信:《ICD-11 与 DSM-5 心境障碍分类的趋同与分歧》
Turk Psikiyatri Derg. 2021;32(4):293-295. doi: 10.5080/u26899.
7
Major Differences in Neurooxidative and Neuronitrosative Stress Pathways Between Major Depressive Disorder and Types I and II Bipolar Disorder.主要的神经氧化应激和神经元硝化应激途径在重度抑郁症和 I 型及 II 型双相障碍之间的差异。
Mol Neurobiol. 2019 Jan;56(1):141-156. doi: 10.1007/s12035-018-1051-7. Epub 2018 Apr 21.
8
Forecasting Mood in Bipolar Disorder From Smartphone Self-assessments: Hierarchical Bayesian Approach.从智能手机自我评估中预测双相情感障碍的情绪:分层贝叶斯方法。
JMIR Mhealth Uhealth. 2020 Apr 1;8(4):e15028. doi: 10.2196/15028.
9
Classifying mood disorders by age-at-onset instead of polarity.根据发病年龄而非极性对情绪障碍进行分类。
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):86-93. doi: 10.1016/j.pnpbp.2008.10.007. Epub 2008 Oct 27.
10
Multimodal digital assessment of depression with actigraphy and app in Hong Kong Chinese.基于活动监测和应用的香港中文人群抑郁的多模态数字化评估
Transl Psychiatry. 2024 Mar 18;14(1):150. doi: 10.1038/s41398-024-02873-4.

引用本文的文献

1
The implementation of digital biomarkers in the diagnosis, treatment and monitoring of mood disorders: a narrative review.数字生物标志物在情绪障碍诊断、治疗和监测中的应用:一篇叙述性综述。
Front Digit Health. 2025 Jun 17;7:1595243. doi: 10.3389/fdgth.2025.1595243. eCollection 2025.
2
Development of a Cohesive Predictive Model for Substance Use Disorder Rehabilitation Using Passive Digital Biomarkers, Psychological Assessments, and Automated Facial Emotion Recognition: Protocol for a Prospective Cohort Study.使用被动数字生物标志物、心理评估和自动面部情绪识别开发物质使用障碍康复的连贯预测模型:一项前瞻性队列研究方案
JMIR Res Protoc. 2025 Jun 27;14:e71374. doi: 10.2196/71374.
3

本文引用的文献

1
Digital Phenotyping for Differential Diagnosis of Major Depressive Episode: Narrative Review.用于重度抑郁发作鉴别诊断的数字表型分析:叙述性综述
JMIR Ment Health. 2023 Jan 23;10:e37225. doi: 10.2196/37225.
2
Accelerating Medicines Partnership Schizophrenia (AMP SCZ): developing tools to enable early intervention in the psychosis high risk state.加速药物合作精神分裂症项目(AMP SCZ):开发工具以实现对精神病高危状态的早期干预。
World Psychiatry. 2023 Feb;22(1):42-43. doi: 10.1002/wps.21038.
3
Smartphone app engagement and clinical outcomes in a hybrid clinic.
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program.
加速药物合作组织精神分裂症项目中的数字健康技术
Schizophrenia (Heidelb). 2025 Jun 3;11(1):83. doi: 10.1038/s41537-025-00599-w.
4
Using Digital Phenotyping to Discriminate Unipolar Depression and Bipolar Disorder: Systematic Review.利用数字表型鉴别单相抑郁和双相情感障碍:系统评价
J Med Internet Res. 2025 May 23;27:e72229. doi: 10.2196/72229.
5
Revolutionizing Medicine: Chatbots as Catalysts for Improved Diagnosis, Treatment, and Patient Support.变革医学:聊天机器人成为改善诊断、治疗及患者支持的催化剂。
Cureus. 2025 Mar 21;17(3):e80935. doi: 10.7759/cureus.80935. eCollection 2025 Mar.
6
Machine Learning for Mental Health: Applications, Challenges, and the Clinician's Role.心理健康领域的机器学习:应用、挑战及临床医生的角色
Curr Psychiatry Rep. 2024 Dec;26(12):694-702. doi: 10.1007/s11920-024-01561-w. Epub 2024 Nov 11.
7
Digital Tools to Facilitate the Detection and Treatment of Bipolar Disorder: Key Developments and Future Directions.数字工具促进双相情感障碍的检测和治疗:关键进展和未来方向。
JMIR Ment Health. 2024 Apr 1;11:e58631. doi: 10.2196/58631.
智能手机应用程序参与度与混合诊所的临床结局。
Psychiatry Res. 2023 Jan;319:115015. doi: 10.1016/j.psychres.2022.115015. Epub 2022 Dec 18.
4
Exploring the digital footprint of depression: a PRISMA systematic literature review of the empirical evidence.探索抑郁症的数字足迹:一项关于实证证据的 PRISMA 系统文献综述。
BMC Psychiatry. 2022 Jun 22;22(1):421. doi: 10.1186/s12888-022-04013-y.
5
Enabling Research and Clinical Use of Patient-Generated Health Data (the mindLAMP Platform): Digital Phenotyping Study.启用患者生成健康数据的研究和临床应用(mindLAMP 平台):数字表型研究。
JMIR Mhealth Uhealth. 2022 Jan 7;10(1):e30557. doi: 10.2196/30557.
6
Automatically Generated Smartphone Data in Young Patients With Newly Diagnosed Bipolar Disorder and Healthy Controls.新诊断双相情感障碍的年轻患者及健康对照者的自动生成的智能手机数据
Front Psychiatry. 2021 Aug 25;12:559954. doi: 10.3389/fpsyt.2021.559954. eCollection 2021.
7
Smartphones and the Neuroscience of Mental Health.智能手机与精神健康的神经科学
Annu Rev Neurosci. 2021 Jul 8;44:129-151. doi: 10.1146/annurev-neuro-101220-014053. Epub 2021 Feb 8.
8
Digital health developments and drawbacks: a review and analysis of top-returned apps for bipolar disorder.数字健康的发展与弊端:双相情感障碍顶级热门应用的综述与分析
Int J Bipolar Disord. 2020 Dec 1;8(1):39. doi: 10.1186/s40345-020-00202-4.
9
Bipolar spectrum in major depressive disorders.双相谱系障碍在重性抑郁障碍中的表现。
Eur Arch Psychiatry Clin Neurosci. 2018 Dec;268(8):741-748. doi: 10.1007/s00406-018-0927-x. Epub 2018 Jul 21.
10
Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders.抑郁症中差异蛋白质组学表达研究的可行性:对情绪障碍生物标志物开发的启示
Transl Psychiatry. 2015 Dec 8;5(12):e689. doi: 10.1038/tp.2015.185.